Aurora kinase inhibitors

被引：73
|
作者：
Kitzen, J. J. E. M. [1 ]
de Jonge, M. J. A. [1 ]
Verweij, J. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2010年 / 73卷 / 02期
关键词：
Aurora kinase; Aurora kinase inhibitor; Aurora-A; Aurora-B; Aurora-C; Pre-clinical; Phase I; CHROMOSOMAL PASSENGER PROTEIN; AMPLIFICATION; REVEALS; YEAST; GENE; MCAK; PHOSPHORYLATION; IDENTIFICATION; PHOSPHATASE-1; ASSOCIATION;
D O I：
10.1016/j.critrevonc.2009.03.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Most human cancer cells are characterized by changes in the amount or organization of DNA resulting in chromosome instability and aneuploidy. Several mitotic kinases, Aurora kinases amongst others, regulate the progression of the cell through mitosis. So far three Aurora kinases have been identified in man: Aurora-A, Aurora-B and Aurora-C. Aurora kinases were recently identified as a potential target in anticancer therapy, and various Aurora-A and Aurora-B kinase inhibitors are in development. In this review we provide a brief insight into the mechanism of action as far as currently available. We review the available pre-clinical data, discuss the clinical phase I data and try to give a direction for future headings. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：99 / 110
页数：12
相关论文
共 50 条
  • [31] Synthesis and characterization of pyrazoleanthrone derivatives as Aurora A kinase inhibitors
    Xiao-xiao Sun
    Tao Sun
    Tai-yi Wang
    Yan Zhang
    Hui-juan Liu
    Quan Wang
    Guo-jun Niu
    Wei Liu
    Hong-gang Zhou
    Cheng Yang
    Chemical Research in Chinese Universities, 2013, 29 : 1098 - 1103
  • [32] Virtual Screening and Discovery of Novel Aurora Kinase Inhibitors
    Raghu, R.
    Devaraji, Vinod
    Leena, K.
    Riyaz, Sd.
    Rani, Polavaru Baby
    Kumar, Suneel B.
    Naik, Pradeep Kumar
    Dubey, P. K.
    Velmurugan, Devadasan
    Vijayalakshmi, M.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (17) : 2006 - 2019
  • [33] Aurora kinase inhibitors as anti-cancer therapy
    Lok, Warren
    Klein, Rhonda Q.
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2010, 21 (04) : 339 - 350
  • [34] Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
    Dar, Altaf A.
    Goff, Laura W.
    Majid, Shahana
    Berlin, Jordan
    El-Rifai, Wael
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (02) : 268 - 278
  • [35] Aurora kinase inhibitors: more than one opportunity?
    Laffranchi, B.
    Moll, J.
    Comis, S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 79 - 80
  • [36] Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agents
    Pollard, John R.
    Mortimore, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 2629 - 2651
  • [37] How to Design Aurora Kinase A Selective Inhibitors.
    Kosmopoulou, Magda
    Faisal, Amir
    Sun, Chongbo
    Bavetsias, Vassilios
    Atrash, Butrus
    Bouloc, Nathalie
    Matteucci, Mizio
    Blagg, Julian
    Linardopoulos, Spiros
    Bayliss, Richard
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S148 - S149
  • [38] De novo design and optimization of Aurora A kinase inhibitors
    Rodrigues, Tiago
    Roudnicky, Filip
    Koch, Christian P.
    Kudoh, Takayuki
    Reker, Daniel
    Detmar, Michael
    Schneider, Gisbert
    CHEMICAL SCIENCE, 2013, 4 (03) : 1229 - 1233
  • [39] Aurora-B Kinase Inhibitors for Cancer Chemotherapy
    Yeung, Sai-Ching Jim
    Gully, Christopher
    Lee, Mong-Hong
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (14) : 1514 - 1525
  • [40] Design and synthesis of Aurora kinase inhibitors as anticancer agents
    Hsu, Yung Chang
    Shiao, Hui-Yi
    Lin, Wen-Hsing
    Hsu, John Tsu-An
    Chen, Chiung-Tong
    Chao, Yu-Sheng
    Hsieh, Hsing-Pang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
12345